Bacterial Vaginosis in Pregnancy: Detection by Weekly Vaginal pH Testing

Interventional study to assess the effect of early detection and treatment of bacterial vaginosis in pregnancy on preterm delivery rate.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pregnancy Bacterial Infections Bacterial Infections and Mycoses Bacterial Vaginosis Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Infections Obstetric Labor Complications Obstetric Labor, Premature Pregnancy Complications Premature Birth Preterm Delivery Urogenital Diseases Vaginal Diseases Vaginitis Vaginosis, Bacterial

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Clinic

Barcelona, Catalonia, 08036, Spain

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Pregnant women

Exclusion criteria

Diabetes mellitus (pre-gestational)
Hypertension (pre-gestational)
Malformations on ultrasonography at 12 weeks

Treatment and study plan

Screening

Other

Weekly vaginal pH

Primary outcomes

Preterm delivery rate

Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Montse Palacio

Other

Registry information

Official study title

Impact on Prematurity of a First-trimester Screening for Bacterial Vaginosis in Pregnancy Through Weekly Vaginal pH Determination. An Interventional, Community Study.

Important dates

Study start: 2007
Primary completion: 2010
Study completion: 2010
First posted: Dec 1, 2008
Registry last updated: Apr 5, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed